يعرض 1 - 10 نتائج من 140 نتيجة بحث عن '"enfermedad arterial coronaria"', وقت الاستعلام: 0.71s تنقيح النتائج
  1. 1
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية

    المصدر: Revista Información Científica; Vol. 102 (2023); 4108 ; 1028-9933

    وصف الملف: application/pdf; application/xml; application/epub+zip

    العلاقة: https://revinfcientifica.sld.cu/index.php/ric/article/view/4108/5624Test; https://revinfcientifica.sld.cu/index.php/ric/article/view/4108/5744Test; https://revinfcientifica.sld.cu/index.php/ric/article/view/4108/5666Test; https://revinfcientifica.sld.cu/index.php/ric/article/view/4108/5626Test; https://revinfcientifica.sld.cu/index.php/ric/article/view/4108/5746Test; https://revinfcientifica.sld.cu/index.php/ric/article/view/4108/5636Test; Fox KAA, Metra M, Morais J, Atar D. The myth of ‘stable’ coronary artery disease. Nat Rev Cardiol [Internet]. 2020 [citado 20 Dic 2022]; 17(1):9-21. Disponible en: https://www.nature.com/articles/s41569-019-0233-yTest; Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, Mintz GS, et al. A Prospective Natural-History Study of Coronary Atherosclerosis. N Engl J Med [Internet]. 2011 [citado 20 Dic 2022]; 364(3):226-35. DOI: https://doi.org/10.1056/nejmoa1002358Test; Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, et al. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. N Engl J Med [Internet]. 2015 [citado 20 Dic 2022]; 372(25):2387-97. DOI: https://doi.org/10.1056/nejmoa1410489Test; Katritsis DG, et al. Guía ESC 2019 sobre el tratamiento de pacientes con taquicardia supraventricular. Rev Esp Cardiol [Internet]. 2020 Jun [citado 20 Dic 2022]; 73(6):496.e1-496.e60. DOI: https://doi.org/10.1016/j.recesp.2019.12.029Test; Eisen A, Bhatt DL, Steg PG, Eagle KA, Goto S, Guo J, et al. Angina and future cardiovascular events in stable patients with coronary artery disease: Insights from the Reduction of Atherothrombosis for Continued Health (REACH) Registry. J Am Heart Assoc [Internet]. 2016 [citado 20 Dic 2022]; 5(10). DOI: https://doi.org/10.1161/JAHA.116.004080Test; Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, et al. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med [Internet]. 2015 [citado 20 Dic 2022]; 373(22):17-28. DOI: https://doi.org/10.1056/nejmoa1504720Test; Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JFE, Nauck MA, et al. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med [Internet]. 2016 [citado 20 Dic 2022]; 375(4):311-22. DOI: https://doi.org/10.1056/nejmoa1603827Test; Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jódar E, Leiter LA, et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med [Internet]. 2016 [citado 20 Dic 2022]; 375(19):1834-1844. Disponible en: https://doi.org/10.1056/nejmoa1607141Test; https://revinfcientifica.sld.cu/index.php/ric/article/view/4108Test

  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية
  7. 7
  8. 8
  9. 9
    دورية أكاديمية

    المصدر: Cuban Journal of Cardiology and Cardiovascular Surgery; Vol. 28, No. 1 (2022): Enero-Marzo; e1084 ; Revista Cubana de Cardiología y Cirugía Cardiovascular; Vol. 28, No. 1 (2022): Enero-Marzo; e1084 ; 1561-2937

    وصف الملف: application/pdf

    العلاقة: https://revcardiologia.sld.cu/index.php/revcardiologia/article/view/1084/pdfTest; Novack K, Vrdoljak D, Jelaska I, Borovac JA. Sex-specific differences in risk factors for in-hospital mortality and complications in patients with acute coronary syndromes. Wien KlinWochenschr[Internet]. 2017Apr [cited 2019Apr17];129(7-8):232-42. Available from: https://link.springer.com/content/pdf/10.1007%2Fs00508-016-1105-7.pdfTest Merz CNB, RamineniT, Leong D. Sex-specific risk factors for cardiovascular disease in women-making cardiovascular disease real. CurrOpinCardiol 2018; 33:500–505. DOI:10.1097/HCO. 0000000000000543. García M. Factores de riesgo cardiovascular desde la perspectiva de sexo y género. Rev Colomb Cardiol. 2018;25(S1):8---12. https://doi.org/10.1016/j.rccar.2017.11.021Test. Grandi SM, Filion KB, Yoon S, Ayele HT, Doyle CM, Hutcheon JA, et al. Cardiovascular disease related morbidity and mortality in women with a history of pregnancy complications. Circulation. 2019; 139:1069–1079. doi:10.1161/ CIRCULATIONAHA.118.036748. Wu P, Haththotuwa R, Kwok CS, Babu A, Kotronias RA, Rushton C et al. Preeclampsia and Future Cardiovascular Health A Systematic Review and Meta-Analysis. CircCardiovascQualOutcomes. 2017; 10: e003497. DOI:10.1161/CIRCOUTCOMES.116.003497. Valdés G. Preeclampsia y enfermedad cardiovascular: un enfoque integral para detectar las fases subclínicas de complicaciones obstétricas y cardiovasculares. Rev ChilCardiol 2019; 38: 132-145. Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden CH, Budaj A, et al. Guía de prácticas clínicas de la ESC sobre diagnóstico y tratamiento de la cardiopatía isquémica estable. Rev Esp Cardiol [Internet]. 2014 Ene [citado 23 Abr 2019];67(2):80-86. Disponible en: https://www.revespcardiol.org/es-pdf-S030089321400030XTest.; McDonald SD, Ray J, Teo K, et al. Measures of cardiovascular risk and subclinical atherosclerosis in a cohort of women with a remote history of preeclampsia. Atherosclerosis. 2013;229(1):234-239. Wu P, Mamas AM. Gulati M. Pregnancy as a predictor of maternal cardiovascular disease: The era of CardioObstetrics. Journal of Women's Health. 2019; 28.8: 1037-1050.; Daly B, Toulis KA, Thomas N, Gokhale K, Martin J, Web-ber J, et al. Increased risk of ischemic heart disease, hypertension, and type 2 diabetes in women with previous gestational diabetes mellitus, a target group in general practice for preventive interventions: A population based cohort study. PLoSMed. 2018;15(1): e1002488,http://dx.doi.org/10.1371/journal.pmed.1002488.4Test; Basily Smith GD, Whitley E, Gissler M, Hemminki E. Birth dimensions of offspring, premature birth, and the mortality of mothers. The Lancet. 2000; 356 (9247) :2066-2067. https://doi.org/10.1016/j.amjmed.2018.11.029Test Kramer C K, Campbell S, Retnakaran R. Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis. Diabetologia. 2019; 62(6): 905-914. Duran A. Diabetes gestacional: ¿Es tiempo de cambiar el riesgo cardiovascular en las mujeres? Endocrinología, Diabetes y Nutrición. 2019; 66(4): 207-209. https://doi.org/10.1016/j.endinu.2019.03.002Test; Risse HK, Sulo G, Tell GS, Igland J, Nygard O, Vollset SE, et al. Incident coronary heart disease after preeclampsia: Role of reduced fetal growth, preterm delivery, and parity. J Am Heart Assoc 2017;6: e004158 Saldarriaga CI, Franco G, Garzón AM, García I, Mejía N, Restrepo A. Factores de riesgo para la enfermedad coronaria temprana en mujeres. Biomédica 2010; 30:559-66.; https://revcardiologia.sld.cu/index.php/revcardiologia/article/view/1084Test

  10. 10
    دورية أكاديمية

    المصدر: Cuban Journal of Cardiology and Cardiovascular Surgery; Vol. 28, No. 1 (2022): Enero-Marzo; e1084 ; Revista Cubana de Cardiología y Cirugía Cardiovascular; Vol. 28, No. 1 (2022): Enero-Marzo; e1084 ; 1561-2937

    وصف الملف: application/pdf

    العلاقة: http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/view/1084/pdfTest; Novack K, Vrdoljak D, Jelaska I, Borovac JA. Sex-specific differences in risk factors for in-hospital mortality and complications in patients with acute coronary syndromes. Wien KlinWochenschr[Internet]. 2017Apr [cited 2019Apr17];129(7-8):232-42. Available from: https://link.springer.com/content/pdf/10.1007%2Fs00508-016-1105-7.pdfTest Merz CNB, RamineniT, Leong D. Sex-specific risk factors for cardiovascular disease in women-making cardiovascular disease real. CurrOpinCardiol 2018; 33:500–505. DOI:10.1097/HCO. 0000000000000543. García M. Factores de riesgo cardiovascular desde la perspectiva de sexo y género. Rev Colomb Cardiol. 2018;25(S1):8---12. https://doi.org/10.1016/j.rccar.2017.11.021Test. Grandi SM, Filion KB, Yoon S, Ayele HT, Doyle CM, Hutcheon JA, et al. Cardiovascular disease related morbidity and mortality in women with a history of pregnancy complications. Circulation. 2019; 139:1069–1079. doi:10.1161/ CIRCULATIONAHA.118.036748. Wu P, Haththotuwa R, Kwok CS, Babu A, Kotronias RA, Rushton C et al. Preeclampsia and Future Cardiovascular Health A Systematic Review and Meta-Analysis. CircCardiovascQualOutcomes. 2017; 10: e003497. DOI:10.1161/CIRCOUTCOMES.116.003497. Valdés G. Preeclampsia y enfermedad cardiovascular: un enfoque integral para detectar las fases subclínicas de complicaciones obstétricas y cardiovasculares. Rev ChilCardiol 2019; 38: 132-145. Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden CH, Budaj A, et al. Guía de prácticas clínicas de la ESC sobre diagnóstico y tratamiento de la cardiopatía isquémica estable. Rev Esp Cardiol [Internet]. 2014 Ene [citado 23 Abr 2019];67(2):80-86. Disponible en: https://www.revespcardiol.org/es-pdf-S030089321400030XTest.; McDonald SD, Ray J, Teo K, et al. Measures of cardiovascular risk and subclinical atherosclerosis in a cohort of women with a remote history of preeclampsia. Atherosclerosis. 2013;229(1):234-239. Wu P, Mamas AM. Gulati M. Pregnancy as a predictor of maternal cardiovascular disease: The era of CardioObstetrics. Journal of Women's Health. 2019; 28.8: 1037-1050.; Daly B, Toulis KA, Thomas N, Gokhale K, Martin J, Web-ber J, et al. Increased risk of ischemic heart disease, hypertension, and type 2 diabetes in women with previous gestational diabetes mellitus, a target group in general practice for preventive interventions: A population based cohort study. PLoSMed. 2018;15(1): e1002488,http://dx.doi.org/10.1371/journal.pmed.1002488.4Test; Basily Smith GD, Whitley E, Gissler M, Hemminki E. Birth dimensions of offspring, premature birth, and the mortality of mothers. The Lancet. 2000; 356 (9247) :2066-2067. https://doi.org/10.1016/j.amjmed.2018.11.029Test Kramer C K, Campbell S, Retnakaran R. Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis. Diabetologia. 2019; 62(6): 905-914. Duran A. Diabetes gestacional: ¿Es tiempo de cambiar el riesgo cardiovascular en las mujeres? Endocrinología, Diabetes y Nutrición. 2019; 66(4): 207-209. https://doi.org/10.1016/j.endinu.2019.03.002Test; Risse HK, Sulo G, Tell GS, Igland J, Nygard O, Vollset SE, et al. Incident coronary heart disease after preeclampsia: Role of reduced fetal growth, preterm delivery, and parity. J Am Heart Assoc 2017;6: e004158 Saldarriaga CI, Franco G, Garzón AM, García I, Mejía N, Restrepo A. Factores de riesgo para la enfermedad coronaria temprana en mujeres. Biomédica 2010; 30:559-66.; http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/view/1084Test